This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

PATH Resources

Our online catalog indexes publications, presentations, and related resources for peers in our field.

102 Resources
102 Resources
102 Resources
    Date
  1. National malaria control programs (NMCPs) are frequently faced with making decisions that require trade-offs in order to best allocate scarce resources to control and eliminate malaria. With limited budgets, NMCPs need to choose how to fund staff, research, operations, essential drugs and diagnostics, and many other items in a manner that maximizes the potential impact on reducing malaria. A mismatch between product characteristics and NMCP need will result in overspending and opportunity costs because those wasted funds could have been used elsewhere.This fact sheet explores these potential downstream consequences for NMCPs of upstream decisions made during the product development process on two examples related to diagnostics used in malaria case management.
    Published: June 2020
    Type: Resource Page
  2. As COVID-19 spreads around the world, PATH in India is working to lessen its impact. PATH is partnering with governments, innovators, and peers across the country to plug the gaps in health systems and provide support to develop and strengthen systems that are preventing, identifying, tracking, and responding to the COVID-19 outbreak. This includes policy, preparedness, information, education and communications support, capacity-building and strengthening, digital and data strategies, accelerating innovations, and collaboration with partners.
    Published: May 2020
    Type: Resource Page
  3. SARS-CoV-2: PATH’S RESPONSEFor more than 40 years, PATH has been working to increase access to health interventions, improve quality of care, and achieve health equity. With expertise in global health security, vaccines and immunization, data systems, surveillance and diagnostics under one roof, health experts at PATH can implement holistic solutions. Today, our global team of more than 1,400 is at work in 70 countries, partnering across ministries, governments, and the private sector to develop and roll out lifesaving vaccines, create affordable diagnostic tools, and scale our impact through advocacy and policy efforts.For the COVID-19 outbreak, we are supporting the immediate response by expanding our existing work to help countries be ready to deploy testing, surveillance, mitigation strategies, and solutions to improve health systems. We’re also helping countries identifying health systems strengthening opportunities that will address longer-term concerns.
    Published: April 2020
    Type: Resource Page
  4. In low- and middle-income countries, many women experience anemia during pregnancy due to insufficient dietary intake of key micronutrients, parasitic infections, hemoglobinopathies, and chronic infections. Maternal anemia increases perinatal risks for both mothers and infants, and slow progress to reduce the prevalence may be due in part to the lack of affordable tools to quantify hemoglobin levels in antenatal care (ANC) clinics. A simple, inexpensive, accurate, and robust diagnostic is needed to measure hemoglobin in ANC.PATH sought to understand and assess the accuracy and operational fit of current anemia diagnostic tools. Our approach began with the development of a target product profile and a landscape of commercially available/emerging diagnostics for anemia testing.We then identified promising candidate technologies and conducted laboratory verification testing and usability testing in a representative ANC setting.This project resulted in a body of evidence that can be used to evaluate and select promising anemia diagnostic technologies to take to scale now and in the future.
    Published: March 2020
    Type: Resource Page
  5. Currently, there is limited availability of diagnostic tests for G6PD deficiency, appropriate for widespread use in malaria endemic regions. This creates a challenge to ensuring safe, radical cure treatment for malaria patients. The purpose of this call is to solicit information from companies that are working on G6PD diagnostic solutions, with the potential to address testing needs in low- and middle-income countries (LMICs), particularly in non-laboratory settings. Select companies with available prototypes will be considered for participation in future laboratory and operational evaluations, including field studies in LMICs, to further support product development.
    Published: February 2020
    Type: Resource Page
Load more